BSE Live
Jan 30, 16:01Prev. Close
62.14
Open Price
62.10
Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
0.00 (0)
NSE Live
Jan 30, 15:42Prev. Close
61.90
Open Price
62.99
Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
0.00 (0)
| Cash Flow of Brooks Laboratories (in Rs. Cr.) | Mar 25 | Mar 24 | Mar 23 | Mar 22 | Mar 21 | |
| 12 mths | 12 mths | 12 mths | 12 mths | 12 mths | ||
| Net Profit/Loss Before Extraordinary Items And Tax | -9.79 | -19.57 | -35.43 | -23.90 | -8.99 | |
| Net CashFlow From Operating Activities | 2.63 | -9.68 | -14.49 | -37.44 | 4.46 | |
| Net Cash Used In Investing Activities | -45.14 | 0.18 | 0.49 | -24.91 | -5.13 | |
| Net Cash Used From Financing Activities | 42.43 | 9.60 | 11.41 | 64.07 | 1.16 | |
| Foreign Exchange Gains / Losses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Adjustments On Amalgamation Merger Demerger Others | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Net Inc/Dec In Cash And Cash Equivalents | -0.08 | 0.10 | -2.58 | 1.72 | 0.49 | |
| Cash And Cash Equivalents Begin of Year | 0.13 | 0.02 | 2.61 | 0.88 | 0.40 | |
| Cash And Cash Equivalents End Of Year | 0.04 | 0.13 | 0.02 | 2.61 | 0.88 |
04.12.2025
Brooks Labs Consolidated September 2025 Net Sales at Rs 23.45 crore, up 12.79% Y-o-Y
27.11.2025
Brooks Labs Standalone September 2025 Net Sales at Rs 23.45 crore, up 12.79% Y-o-Y
12.06.2025
Brooks Labs Standalone March 2025 Net Sales at Rs 23.32 crore, up 31.57% Y-o-Y
05.06.2025
Brooks Labs Consolidated March 2025 Net Sales at Rs 23.32 crore, up 31.57% Y-o-Y
04.12.2025
Brooks Labs Consolidated September 2025 Net Sales at Rs 23.45 crore, up 12.79% Y-o-Y
27.11.2025
Brooks Labs Standalone September 2025 Net Sales at Rs 23.45 crore, up 12.79% Y-o-Y
12.06.2025
Brooks Labs Standalone March 2025 Net Sales at Rs 23.32 crore, up 31.57% Y-o-Y
05.06.2025
Brooks Labs Consolidated March 2025 Net Sales at Rs 23.32 crore, up 31.57% Y-o-Y